CGA · Class II · 21 CFR 862.1345

FDA Product Code CGA: Glucose Oxidase, Glucose

Leading manufacturers include Abbott Point of Care, Inc., Nova Biomedical Corporation and Ysi, Inc..

401
Total
401
Cleared
129d
Avg days
1976
Since
Declining activity - 3 submissions in the last 2 years vs 5 in the prior period
Review times increasing: avg 817d recently vs 124d historically

FDA 510(k) Cleared Glucose Oxidase, Glucose Devices (Product Code CGA)

401 devices
1–24 of 401

About Product Code CGA - Regulatory Context

510(k) Submission Activity

401 total 510(k) submissions under product code CGA since 1976, with 401 receiving FDA clearance (average review time: 129 days).

Submission volume has declined in recent years - 3 submissions in the last 24 months compared to 5 in the prior period.

FDA Review Time

Recent submissions under CGA have taken an average of 817 days to reach a decision - up from 124 days historically. Manufacturers should account for longer review timelines in current project planning.

CGA devices are reviewed by the Chemistry panel. Browse all Chemistry devices →